Cargando…

Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases

The widespread use of Cas12a (formerly Cpf1) nucleases for genome engineering is limited by their requirement for a rather long TTTV protospacer adjacent motif (PAM) sequence. Here we have aimed to loosen these PAM constraints and have generated new PAM mutant variants of the four Cas12a orthologs t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tóth, Eszter, Varga, Éva, Kulcsár, Péter István, Kocsis-Jutka, Virág, Krausz, Sarah Laura, Nyeste, Antal, Welker, Zsombor, Huszár, Krisztina, Ligeti, Zoltán, Tálas, András, Welker, Ervin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144938/
https://www.ncbi.nlm.nih.gov/pubmed/32107556
http://dx.doi.org/10.1093/nar/gkaa110
_version_ 1783519909179817984
author Tóth, Eszter
Varga, Éva
Kulcsár, Péter István
Kocsis-Jutka, Virág
Krausz, Sarah Laura
Nyeste, Antal
Welker, Zsombor
Huszár, Krisztina
Ligeti, Zoltán
Tálas, András
Welker, Ervin
author_facet Tóth, Eszter
Varga, Éva
Kulcsár, Péter István
Kocsis-Jutka, Virág
Krausz, Sarah Laura
Nyeste, Antal
Welker, Zsombor
Huszár, Krisztina
Ligeti, Zoltán
Tálas, András
Welker, Ervin
author_sort Tóth, Eszter
collection PubMed
description The widespread use of Cas12a (formerly Cpf1) nucleases for genome engineering is limited by their requirement for a rather long TTTV protospacer adjacent motif (PAM) sequence. Here we have aimed to loosen these PAM constraints and have generated new PAM mutant variants of the four Cas12a orthologs that are active in mammalian and plant cells, by combining the mutations of their corresponding RR and RVR variants with altered PAM specificities. LbCas12a-RVRR showing the highest activity was selected for an in-depth characterization of its PAM preferences in mammalian cells, using a plasmid-based assay. The consensus PAM sequence of LbCas12a-RVRR resembles a TNTN motif, but also includes TACV, TTCV CTCV and CCCV. The D156R mutation in improved LbCas12a (impLbCas12a) was found to further increase the activity of that variant in a PAM-dependent manner. Due to the overlapping but still different PAM preferences of impLbCas12a and the recently reported enAsCas12a variant, they complement each other to provide increased efficiency for genome editing and transcriptome modulating applications.
format Online
Article
Text
id pubmed-7144938
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71449382020-04-13 Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases Tóth, Eszter Varga, Éva Kulcsár, Péter István Kocsis-Jutka, Virág Krausz, Sarah Laura Nyeste, Antal Welker, Zsombor Huszár, Krisztina Ligeti, Zoltán Tálas, András Welker, Ervin Nucleic Acids Res Molecular Biology The widespread use of Cas12a (formerly Cpf1) nucleases for genome engineering is limited by their requirement for a rather long TTTV protospacer adjacent motif (PAM) sequence. Here we have aimed to loosen these PAM constraints and have generated new PAM mutant variants of the four Cas12a orthologs that are active in mammalian and plant cells, by combining the mutations of their corresponding RR and RVR variants with altered PAM specificities. LbCas12a-RVRR showing the highest activity was selected for an in-depth characterization of its PAM preferences in mammalian cells, using a plasmid-based assay. The consensus PAM sequence of LbCas12a-RVRR resembles a TNTN motif, but also includes TACV, TTCV CTCV and CCCV. The D156R mutation in improved LbCas12a (impLbCas12a) was found to further increase the activity of that variant in a PAM-dependent manner. Due to the overlapping but still different PAM preferences of impLbCas12a and the recently reported enAsCas12a variant, they complement each other to provide increased efficiency for genome editing and transcriptome modulating applications. Oxford University Press 2020-04-17 2020-02-28 /pmc/articles/PMC7144938/ /pubmed/32107556 http://dx.doi.org/10.1093/nar/gkaa110 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Molecular Biology
Tóth, Eszter
Varga, Éva
Kulcsár, Péter István
Kocsis-Jutka, Virág
Krausz, Sarah Laura
Nyeste, Antal
Welker, Zsombor
Huszár, Krisztina
Ligeti, Zoltán
Tálas, András
Welker, Ervin
Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases
title Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases
title_full Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases
title_fullStr Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases
title_full_unstemmed Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases
title_short Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases
title_sort improved lbcas12a variants with altered pam specificities further broaden the genome targeting range of cas12a nucleases
topic Molecular Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144938/
https://www.ncbi.nlm.nih.gov/pubmed/32107556
http://dx.doi.org/10.1093/nar/gkaa110
work_keys_str_mv AT totheszter improvedlbcas12avariantswithalteredpamspecificitiesfurtherbroadenthegenometargetingrangeofcas12anucleases
AT vargaeva improvedlbcas12avariantswithalteredpamspecificitiesfurtherbroadenthegenometargetingrangeofcas12anucleases
AT kulcsarpeteristvan improvedlbcas12avariantswithalteredpamspecificitiesfurtherbroadenthegenometargetingrangeofcas12anucleases
AT kocsisjutkavirag improvedlbcas12avariantswithalteredpamspecificitiesfurtherbroadenthegenometargetingrangeofcas12anucleases
AT krauszsarahlaura improvedlbcas12avariantswithalteredpamspecificitiesfurtherbroadenthegenometargetingrangeofcas12anucleases
AT nyesteantal improvedlbcas12avariantswithalteredpamspecificitiesfurtherbroadenthegenometargetingrangeofcas12anucleases
AT welkerzsombor improvedlbcas12avariantswithalteredpamspecificitiesfurtherbroadenthegenometargetingrangeofcas12anucleases
AT huszarkrisztina improvedlbcas12avariantswithalteredpamspecificitiesfurtherbroadenthegenometargetingrangeofcas12anucleases
AT ligetizoltan improvedlbcas12avariantswithalteredpamspecificitiesfurtherbroadenthegenometargetingrangeofcas12anucleases
AT talasandras improvedlbcas12avariantswithalteredpamspecificitiesfurtherbroadenthegenometargetingrangeofcas12anucleases
AT welkerervin improvedlbcas12avariantswithalteredpamspecificitiesfurtherbroadenthegenometargetingrangeofcas12anucleases